Condition

Recurrent Grade 3 Follicular Lymphoma

ClinicalTrials.gov condition label

Clinical trials12
Recruiting0
Common interventions25
Lead sponsors shown5

Clinical trials

12 shown
Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin LymphomaNCT01769911 · 2015-02-01
WITHDRAWN
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV InfectionNCT02109224 · 2014-09-01
TERMINATED
Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantNCT01558778 · 2012-05-01
WITHDRAWN
Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic MalignanciesNCT01273766 · 2011-01-01
COMPLETED
Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell LymphomasNCT01193842 · 2010-10-06
COMPLETED
Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron OverloadNCT01159067 · 2010-07-01
TERMINATED
RO4929097 and Capecitabine in Treating Patients With Refractory Solid TumorsNCT01158274 · 2010-06-01
COMPLETED
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyNCT00890747 · 2009-08-01
COMPLETED
Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell TransplantNCT00795769 · 2008-08-08
COMPLETED
Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantNCT00408681 · 2006-06-01
COMPLETED
Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaNCT00112723 · 2005-12-01
TERMINATED
Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive CancerNCT00060372 · 2003-04-01
COMPLETED

Common interventions

laboratory biomarker analysisOTHER7Pharmacological StudyOTHER3deferasiroxDRUG2EtoposideDRUG2management of therapy complicationsPROCEDURE2alvocidibDRUG1autologous hematopoietic stem cell transplantationPROCEDURE1capecitabineDRUG1carmustineDRUG1CyclophosphamideDRUG1cytarabineDRUG1Doxorubicin HydrochlorideDRUG1enzyme-linked immunosorbent assayOTHER1gamma-secretase/Notch signalling pathway inhibitor RO4929097DRUG1IbrutinibDRUG1ipilimumabDRUG1lithium carbonateDRUG1melphalanDRUG1musculoskeletal complications management/preventionPROCEDURE1O6-benzylguanineDRUG1ondansetronDRUG1peripheral blood stem cell transplantationPROCEDURE1PrednisoneDRUG1RituximabBIOLOGICAL1sunitinib malateDRUG1

Trial status mix

COMPLETED7
TERMINATED3
WITHDRAWN2

Phase mix

PHASE16
PHASE25
NA3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.